Where is CABHI's headquarters located?

CABHI's headquarters is located in Toronto (Canada).

How many companies has CABHI invested in?

CABHI has invested in 14 companies, including Diamond Therapeutics & Panaxium.

Which companies has CABHI invested in lately?

Scotia Derm & Panaxium are the latest investments by CABHI.

CABHI - 2026 Investor Profile, Portfolio, Team & Investment Trends

1. Diamond Therapeutics

Provider of therapeutics for mental health therapies. The company offers small-molecule based sub-perceptual psilocybin medicines which are psychedelic compounds. The products are FDA and EMA certified and use for treatments for disorders of the central nervous system by modulating selective serotonin receptors and neurotrophic receptor signalling.

Key facts about Diamond Therapeutics

Founded Year: 2018
Location: Toronto (Canada)
Stage: Seed
Employee Count: 8 as on Sep 30, 2026
Investors: Palo Santo, Ripple Capital and 7 Others
Latest Funding Round: Grant (prize money), Nov 28, 2025, $*****

2. Panaxium

Developer of medical equipment for surgeons and neurologists to treat brain injuries. The company has a BMI platform a bioelectronic medicine technology built for surgeons and neurologists to directly intervene and treat brain injuries.

Key facts about Panaxium

Founded Year: 2016
Location: Aix-en-Provence (France)
Stage: Seed
Employee Count: 14 as on Sep 30, 2026
Investors: Ontario Brain Institute, Europa and 1 Other
Latest Funding Round: Grant (prize money), Nov 28, 2025, $*****

3. Moneta Health

It is a brain health digital therapy platform that combines licensed therapists with on-demand access to cognitive exercises, lifestyle education, and strategies. They offer a 60-minute brain health evaluation with a therapist and convenient phone-based exercises available 24/7.

Key facts about Moneta Health

Founded Year: 2023
Location: Tampa (United States)
Stage: Seed
Total Funding till date: $6.7M
Employee Count: 26 as on Sep 30, 2026
Investors: Impact America Fund, True Ventures and 4 Others
Latest Funding Round: Seed, Sep 23, 2025, $*****

4. Sinaptica Therapeutics

Developer of personalized closed-loop neuromodulation therapy for Alzheimer’s Disease. It enhances neuroplasticity via neurostimulation of key brain networks involved in memory. The therapy uses neuronavigation to optimize electrical stimulation of the precuneus, the central hub of the Default Mode Network. The approach is calibrated for each individual based on measurements from MRI, TMS-Evoked potentials (TEPs), and other data, allowing individualized stimulation to achieve optimal response.

Key facts about Sinaptica Therapeutics

Founded Year: 2022
Location: Cambridge (United States)
Stage: Seed
Employee Count: 19 as on Sep 30, 2026
Investors: Sony Innovation Fund and CABHI
Latest Funding Round: Grant (prize money), Nov 28, 2025, $*****

5. RetiSpec

RetiSpec was an early stage medical device startup developing a non-invasive eye scanner for early detection of Alzheimer’s Disease. The company was selected as the finalists at the MassChallenge Boston accelerator & had won 1st place at the JNF Lions-Den competition in Toronto & at the 2016 Partners Connected Health and AARP startup competition in Boston. As of Jan 2017, the company hasn't disclosed its product development details.

Key facts about RetiSpec

Founded Year: 2015
Location: Tel Aviv (Israel)
Stage: Series A
Total Funding till date: $17M
Employee Count: 32 as on Sep 30, 2026
Investors: Lilly, iGan Partners and 9 Others
Latest Funding Round: Series A, Jul 26, 2024, $*****
Highlight: Editors' Pick

View the full list of portfolio companies

CABHI has invested in 14 companies over the last 5 years, with an average of 3 new investments annually in the last 5 years. In 2025, it made 9 investments. Its most recent first time investment was in Scotia Derm.

Here are CABHI's Year-on-Year Investment Trends:

Year	No. of Investments
Year	1^st Round	Follow-on	Total
2026 (YTD)	0	0	0
2025	9	0	9
2024	2	0	2
2023	1	0	1
2022	1	0	1
2021	1	0	1

View all investments by CABHI

CABHI has made 7 investments in Grant (prize money) stage, 6 investments in Seed stage with an average round size of $2.04M and 1 investment in Series A stage with an average round size of $10M.

Here are CABHI's investments by stage:

Stage of entry	No. of Investments
Grant (prize money)	7
Seed	6
Series A	1

Note: We have considered here, only first round of investments

View all investments by CABHI

CABHI has a diverse portfolio, with companies operating in the Life Sciences, HealthTech, Enterprise Applications, Healthcare and High Tech. Notably, it has invested in 11 Tech companies, 8 Enterprise (B2B) companies, 6 Tech hardware companies and at least 4 companies focusing on Consumer (B2C).

Here are CABHI's investments by sector:

Sector	No. of Investments
Life Sciences	8
HealthTech	6
Enterprise Applications	1
Healthcare	1
High Tech	1
Others	4

Note: We have considered here, only first round of investments

View all investments by CABHI

CABHI has made most investments in Canada (9), followed by United States where it has made 3 investments.

Here are CABHI's investments by geography:

Country	No. of Investments
Canada	9
United States	3
France	1
Israel	1

Note: We have considered here, only first round of investments

View all investments by CABHI

CABHI has not made any investment in 2026 so far.

Here are the most recent investments by CABHI:

Filter this list

Date	Company	Location	Round Details	Round Amount	Co-Investors
Nov 28, 2025	Scotia Derm	Canada	Grant (prize money)	3038	-
Nov 28, 2025	Panaxium	France	Grant (prize money)	2173	-
Nov 28, 2025	Neuropeutics	Canada	Grant (prize money)	6969	-
Nov 28, 2025	Theravac Biologics	United States	Grant (prize money)	2435	-
Nov 28, 2025	Juno	Canada	Grant (prize money)	5407	-

See more recent investments made by CABHI

CABHI has a team of 11 members including 2 Partners. CABHI's team does not sit on the board of any company as of now.

View team details of CABHI

Over the past 5 years, 36 investors have co-invested in CABHI's portfolio companies. This includes only funds.

Invested before CABHI: Ontario Brain Institute, First Avenue Ventures and 7 others have invested in rounds before CABHI. There are 4 companies where Ontario Brain Institute has invested before CABHI and 1 company where First Avenue Ventures has invested before CABHI.
Top Co-investors of CABHI: 23 investors entered a company along with CABHI. These include investors like Invest Quebec (3 companies).
Invested after CABHI: A total of 4 investors have invested in CABHI's portfolio after their investments. Top Investors include HaloHealth (1 company) and Birdhouse (1 company).